Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lode Dewulf

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Therapeutic Innovation & Regulatory Science|September 22, 2018
Medicines in Pregnancy-Women and Children First? Time for a Coalition to Address a Substantial Patient NeedLode Dewulf
Therapeutic Innovation & Regulatory Science|September 18, 2018
Patient Engagement by Pharma-Why and How? A Framework for Compliant Patient EngagementLode Dewulf
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 16, 2017
Letter to the Editor: Emerging Guidelines for Patient Engagement in ResearchMarc Boutin, Lode Dewulf
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 5, 2022
Letter to the EditorLode Dewulf, Jim Elliott
The Journal of Allergy and Clinical Immunology|September 5, 2006
Is the allergic rhinitis and its impact on asthma classification useful in daily primary care practice?Helen Van Hoecke, Nathan Vastesaeger, Lode Dewulf, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|May 3, 2016
Position Statement from the European Board and College of Obstetrics & Gynaecology (EBCOG) : The use of medicines during pregnancy: call for actionKristel Van Calsteren, Ksenija Gersak, Hildrun Sundseth, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|May 3, 2016
Position statement from the European Board and College of Obstetrics & Gynaecology (EBCOG): The use of medicines during pregnancy - call for actionKristel Van Calsteren, Ksenija Gersak, Hildrun Sundseth, et al.
Therapeutic Innovation & Regulatory Science|September 18, 2018
Medicines in Pregnancy Forum: Proceedings on Ethical and Legal ConsiderationsDavid B Clemow, Martha R Nolan, Debra L Michaels, et al.
Therapeutic Innovation & Regulatory Science|September 24, 2023
Patient Engagement and Patient Experience Data in Regulatory Review and Health Technology Assessment: A Global Landscape ReviewNeil Bertelsen, Lode Dewulf, Silvia Ferrè, et al.
Therapeutic Innovation & Regulatory Science|September 20, 2018
Clinical Data for Informed Medication Use in Pregnancy: Strengths, Limitations, Gaps, and a Need to Continue Moving ForwardDavid B Clemow, Lode Dewulf, Gideon Koren, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Therapeutic Innovation & Regulatory Science|September 22, 2018
Medicines in Pregnancy-Women and Children First? Time for a Coalition to Address a Substantial Patient NeedLode Dewulf
Therapeutic Innovation & Regulatory Science|September 18, 2018
Patient Engagement by Pharma-Why and How? A Framework for Compliant Patient EngagementLode Dewulf
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 16, 2017
Letter to the Editor: Emerging Guidelines for Patient Engagement in ResearchMarc Boutin, Lode Dewulf
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 5, 2022
Letter to the EditorLode Dewulf, Jim Elliott
The Journal of Allergy and Clinical Immunology|September 5, 2006
Is the allergic rhinitis and its impact on asthma classification useful in daily primary care practice?Helen Van Hoecke, Nathan Vastesaeger, Lode Dewulf, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|May 3, 2016
Position Statement from the European Board and College of Obstetrics & Gynaecology (EBCOG) : The use of medicines during pregnancy: call for actionKristel Van Calsteren, Ksenija Gersak, Hildrun Sundseth, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|May 3, 2016
Position statement from the European Board and College of Obstetrics & Gynaecology (EBCOG): The use of medicines during pregnancy - call for actionKristel Van Calsteren, Ksenija Gersak, Hildrun Sundseth, et al.
Therapeutic Innovation & Regulatory Science|September 18, 2018
Medicines in Pregnancy Forum: Proceedings on Ethical and Legal ConsiderationsDavid B Clemow, Martha R Nolan, Debra L Michaels, et al.
Therapeutic Innovation & Regulatory Science|September 24, 2023
Patient Engagement and Patient Experience Data in Regulatory Review and Health Technology Assessment: A Global Landscape ReviewNeil Bertelsen, Lode Dewulf, Silvia Ferrè, et al.
Therapeutic Innovation & Regulatory Science|September 20, 2018
Clinical Data for Informed Medication Use in Pregnancy: Strengths, Limitations, Gaps, and a Need to Continue Moving ForwardDavid B Clemow, Lode Dewulf, Gideon Koren, et al.
Pageof 2